GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Clinical trial NCT05316935 · RECRUITING

Trial details

NCT number: NCT05316935
Sponsor: Xiaojun Chen
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Endometrial Neoplasms Atypical Endometrial Hyperplasia Progesterone Resistance

Start date: 2022-07-13
Primary completion: 2026-03-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.